Open Clinical Trials

Kathleen Ramos, MD, MS

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study (STOP360AG)

• Kawser H. Iguel (kiguel@uw.edu)
• Maddy Grassy (mgrassy@uw.edu)

Kathleen Ramos, MD, MS

Ensuring Access to Optimal Therapy in CF: The ENACT Study

• Kawser H. Iguel (kiguel@uw.edu)
• Roshni Prabhu (rprabhu@uw.edu)

Kathleen Ramos, MD, MS

Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 when Added to Trikafta

• Kawser H. Iguel (kiguel@uw.edu)
• Roshni Prabhu (rprabhu@uw.edu)

Kathleen Ramos, MD, MS

IV Gallium Study for Patients with Cystic Fibrosis Who Have NTM (ABATE Study)

• Maddy Grassy (mgrassy@uw.edu)
• Kawser H. Iguel (kiguel@uw.edu)

Kathleen Ramos, MD, MS

Lung Transplant READY CF 2: A Multi-site RCT

• Sierra C Knapp (sknapp2@uw.edu)
• Maddy Grassy (mgrassy@uw.edu)
• Lauren Bartlett (lrejman@uw.edu)

Kathleen Ramos, MD, MS

Lung Transplant READY CF 2: CARING CF Ancillary RCT

• Sierra C Knapp (sknapp2@uw.edu)
• Maddy Grassy (mgrassy@uw.edu)
• Lauren Bartlett (lrejman@uw.edu)

Christopher Goss, MD, MSc

4D-710 in Adult Patients with Cystic Fibrosis

• Roshni Prabhu (rprabhu@uw.edu)
• Kawser H. Iguel (kiguel@uw.edu)

Christopher Goss, MD, MSc

A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF

• Roshni Prabhu (rprabhu@uw.edu)
• Kawser H. Iguel (kiguel@uw.edu)

Christopher Goss, MD, MSc

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

• Kawser H. Iguel (kiguel@uw.edu)
• Roshni Prabhu (rprabhu@uw.edu)

Christopher Goss, MD, MSc

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

• Roshni Prabhu (rprabhu@uw.edu)
• Kawser H. Iguel (kiguel@uw.edu)
• Maddy Grassy (mgrassy@uw.edu)

David Au, MD, MS

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

• Brianna Moss (Brianna.Moss@va.gov)

Kristina Crothers, MD

Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

• John Kundzins (john.kundzins@va.gov)

Kristina Crothers, MD

MAS-EXPAND: Personalizing Lung Cancer Screening for Veterans

• Stephanie Magone (Stephanie.Magone@va.gov)

Lucas Donovan, MD, MS

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

• Jennifer McDowell (jennifer.mcdowell@va.gov)

Linzee Mabrey, MD, MSc

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

• Xavier Orain (xorain@uw.edu)

Engi Attia, MD, MPH

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

• Engi Attia (eattia@uw.edu)

Bridget Collins, MD

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)

• Bridget Collins (bfc3@uw.edu)
• Katherine Palaeologus (kpal444@uw.edu)
• Katie Wicklander (kwick11@uw.edu)

Bridget Collins, MD

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (SERANATA)

• Bridget Collins (bfc3@uw.edu)
• Megan Zdancewic (meganz2@uw.edu)

Suha Kadura, MD

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

• JB Ingram (jingra@uw.edu)

Erin Kross, MD

Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers (PICSI-M)

• Erin Kross (ekross@uw.edu)

Peter Leary, MD, PhD

Repurposing Valsartan May Protect Against Pulmonary Hypertension

• Laurie Hogl (lalnaser@uw.edu)

Martha Billings, MD, MS

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

• Morgan Aurelio (mca1@uw.edu)

Lucas Donovan, MD, MS

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

• Brianna Moss (Brianna.moss@va.gov)

Erika Lease, MD

Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates

• Erika Lease (edlease@uw.edu)